Functional Redundancy Between Β1 and Β3 Integrin in Activating the IR/Akt/mTORC1 Signaling Axis to Promote ErbB2-Driven Breast Cancer

Cell Reports - United States
doi 10.1016/j.celrep.2019.09.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

AKT Signaling in ERBB2-amplified Breast Cancer

Pharmacology and Therapeutics
Pharmacology
2016English

Role of Integrin Alpha 5 in ErbB2-Mediated Breast Cancer

2009English

An Insertion Mutation of ERBB2 Enhances Breast Cancer Cell Growth and Confers Resistance to Lapatinib Through AKT Signaling Pathway

Biology Open
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2020English

NRSN2 Promotes Breast Cancer Metastasis by Activating PI3K/AKT/mTOR and NF‑κB Signaling Pathways

Oncology Letters
Cancer ResearchOncology
2019English

PSMA Redirects MAPK to PI3K-AKT Signaling to Promote Prostate Cancer Progression

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2017English

Targeting TAZ-driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Hsp90ab1 Stabilizes LRP5 to Promote Epithelial–mesenchymal Transition via Activating of AKT and WNT/Β-Catenin Signaling Pathways in Gastric Cancer Progression

Oncogene
Cancer ResearchGeneticsMolecular Biology
2018English

Targeting the Ron-Dek Signaling Axis in Breast Cancer

2013English

Bone-Induced Expression of Integrin Β3 Enables Targeted Nanotherapy of Breast Cancer Metastases

Cancer Research
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy